Bo Qiu

3.1k total citations · 2 hit papers
33 papers, 2.0k citations indexed

About

Bo Qiu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Bo Qiu has authored 33 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Bo Qiu's work include Cancer, Hypoxia, and Metabolism (8 papers), MicroRNA in disease regulation (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Bo Qiu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), MicroRNA in disease regulation (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Bo Qiu collaborates with scholars based in China, United States and United Kingdom. Bo Qiu's co-authors include M. Celeste Simon, Katherine K. Matthay, Brian Keith, Bo Li, Joshua D. Ochocki, Daniel Ackerman, Lijoy K. Mathew, Itzhak Nissim, Zandra E. Walton and T. Gade and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Molecular and Cellular Biology.

In The Last Decade

Bo Qiu

31 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fructose-1,6-bisphosphatase opposes renal carcinoma progression

2014 404 citations Bo Li, Bo Qiu et al. Nature profile →
Advancing therapy for neuroblastoma

2022 203 citations Bo Qiu, Katherine K. Matthay Nature Reviews Clinical Oncology profile →

Peers

Bo Qiu

PRM

ONCOL

BIOCH

Peter Buechler Germany

Frank Vanderhoydonc Belgium

Alba Luengo United States

Linchong Sun China

Xiaoqi Liu China

Nadine Rohwer Germany

Ramani Dinavahi United States

Antonio Cigliano Germany

Christopher A. Carter United States

Peter Buechler Germany

Bo Qiu

1.3k ×1.1

1.6k ×1.6

267 ×0.9

PRM

621 ×2.5

ONCOL

85 ×0.3

BIOCH

Citations per year, relative to Bo Qiu Bo Qiu (= 1×) peers Peter Buechler

Countries citing papers authored by Bo Qiu

Since Specialization

Citations

This map shows the geographic impact of Bo Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Qiu more than expected).

Fields of papers citing papers by Bo Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Qiu. The network helps show where Bo Qiu may publish in the future.

Co-authorship network of co-authors of Bo Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Qiu. A scholar is included among the top collaborators of Bo Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Qiu. Bo Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiu, Bo, et al.. (2023). Precision based approach to tailoring radiotherapy in the multidisciplinary management of pediatric central nervous system tumors. SHILAP Revista de lepidopterología. 3(2). 141–149. 3 indexed citations

Qiu, Bo & Katherine K. Matthay. (2022). Advancing therapy for neuroblastoma. Nature Reviews Clinical Oncology. 19(8). 515–533. 203 indexed citations breakdown →

Liu, Zengli, Jialiang Liu, Tianli Chen, et al.. (2022). Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway. Oncogene. 41(20). 2885–2896. 33 indexed citations

Liu, Zengli, Chunxiao Hu, Jialiang Liu, et al.. (2022). BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner. Cellular and Molecular Life Sciences. 79(9). 469–469. 23 indexed citations

Qiu, Bo, Cassie Kline, & Sabine Mueller. (2021). Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges. Frontiers in Oncology. 11. 674596–674596. 9 indexed citations

Yi, Xin, et al.. (2021). ST8SIA6-AS1 promotes the development of hepatocellular carcinoma cells through miR-338-3p/NONO Axis. Digestive and Liver Disease. 53(9). 1192–1200. 10 indexed citations

Chen, Tianli, Kangshuai Li, Zengli Liu, et al.. (2021). WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways. Molecular Therapy. 29(6). 2134–2150. 57 indexed citations

Qiu, Bo, Tianli Chen, Rongqi Sun, et al.. (2019). Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle. EBioMedicine. 50. 166–177. 24 indexed citations

Sun, Rongqi, Tianli Chen, Meng Li, et al.. (2019). PTPN3 suppresses the proliferation and correlates with favorable prognosis of perihilar cholangiocarcinoma by inhibiting AKT phosphorylation. Biomedicine & Pharmacotherapy. 121. 109583–109583. 4 indexed citations

10.

Ochocki, Joshua D., Sanika Khare, Markus Heß, et al.. (2018). Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity. Cell Metabolism. 27(6). 1263–1280.e6. 86 indexed citations

11.

Ackerman, Daniel, Sergey Tumanov, Bo Qiu, et al.. (2018). Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation. Cell Reports. 24(10). 2596–2605.e5. 225 indexed citations

12.

Qiu, Bo & M. Celeste Simon. (2016). BODIPY 493/503 Staining of Neutral Lipid Droplets for Microscopy and Quantification by Flow Cytometry. BIO-PROTOCOL. 6(17). 148 indexed citations

13.

Yan, Yuling, Bo Qiu, Jing Wang, et al.. (2015). High-intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysis. BMJ Open. 5(5). e006886–e006886. 38 indexed citations

14.

Yang, Jingyue, et al.. (2015). p53-p66shc/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma. Toxicology Letters. 238(3). 1–10. 40 indexed citations

15.

Qiu, Bo, Daniel Ackerman, Danielle J. Sanchez, et al.. (2015). HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. Cancer Discovery. 5(6). 652–667. 298 indexed citations

16.

Li, Bo, Bo Qiu, David S.M. Lee, et al.. (2014). Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature. 513(7517). 251–255. 404 indexed citations breakdown →

17.

Zhang, Zhang, et al.. (2014). MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2. Medical Oncology. 31(6). 982–982. 63 indexed citations

18.

Mucaj, Vera, N. Skuli, Bo Qiu, et al.. (2014). MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma. Oncogene. 34(17). 2204–2214. 53 indexed citations

19.

Jiang, Liping, Yuanbo Liang, Bo Qiu, et al.. (2011). Metabolic syndrome and chronic kidney disease in a rural Chinese population. Clinica Chimica Acta. 412(21-22). 1983–1988. 14 indexed citations

20.

Jiang, Liping, Yuanbo Liang, Bo Qiu, et al.. (2010). Prevalence of Chronic Kidney Disease in a Rural Chinese Adult Population: The Handan Eye Study. Nephron Clinical Practice. 114(4). c295–c302. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact